OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genetic Knockout of Fatty Acid Amide Hydrolase Ameliorates Cisplatin-Induced Nephropathy in Mice
Chaoling Chen, Weili Wang, Marissa Raymond, et al.
Molecular Pharmacology (2023) Vol. 103, Iss. 4, pp. 230-240
Closed Access | Times Cited: 5
Chaoling Chen, Weili Wang, Marissa Raymond, et al.
Molecular Pharmacology (2023) Vol. 103, Iss. 4, pp. 230-240
Closed Access | Times Cited: 5
Showing 5 citing articles:
Pre-treatment with β-hydroxybutyrate mitigates cisplatin-induced acute kidney injury
Min Jeong Kim, Young-Suk Kim, Seo Rin Kim, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 695, pp. 149482-149482
Closed Access | Times Cited: 5
Min Jeong Kim, Young-Suk Kim, Seo Rin Kim, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 695, pp. 149482-149482
Closed Access | Times Cited: 5
Effect of cannabinoids on the efficacy and side effects of anticancer therapeutic strategies – Current status of preclinical and clinical research
Robert Ramer, Burkhard Hinz
Pharmacology & Therapeutics (2025), pp. 108851-108851
Closed Access
Robert Ramer, Burkhard Hinz
Pharmacology & Therapeutics (2025), pp. 108851-108851
Closed Access
Mitigation of cisplatin-induced acute kidney injury through oral administration of fatty acid amide hydrolase inhibitor PF-04457845
Chaoling Chen, Weili Wang, Justin L. Poklis, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 392, Iss. 2, pp. 100032-100032
Open Access | Times Cited: 3
Chaoling Chen, Weili Wang, Justin L. Poklis, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 392, Iss. 2, pp. 100032-100032
Open Access | Times Cited: 3
PARVB deficiency alleviates cisplatin-induced tubular injury by inhibiting TAK1 signaling
Aihua Yang, Yanyan Ding, Guo Chen, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 1
Aihua Yang, Yanyan Ding, Guo Chen, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 1
Preventing cisplatin-induced kidney injury through inhibition of fatty acid amide hydrolase
Johannes C K van der Mijn
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 392, Iss. 2, pp. 100044-100044
Closed Access
Johannes C K van der Mijn
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 392, Iss. 2, pp. 100044-100044
Closed Access
